SPG7 (Spastic Paraplegia 7) encodes paraplegin, a mitochondrial metalloproteinase that belongs to the AAA+ (ATPases associated with diverse cellular activities) family of proteins. The SPG7 gene is located on the X chromosome and represents one of the most common genetic causes of hereditary spastic paraplegia (HSP), a group of inherited neurological disorders characterized by progressive lower limb weakness and spasticity. Mutations in SPG7 account for approximately 5-10% of X-linked HSP cases and are also found in some autosomal recessive forms of the disease. The protein functions as part of the m-AAA protease complex within the inner mitochondrial membrane, making it essential for mitochondrial protein quality control and cellular energy metabolism.
Function/Biology
Paraplegin is an ATP-dependent protease that oligomerizes to form a hexameric ring structure capable of unfolding and degrading damaged or misfolded proteins within the mitochondrial matrix and inner membrane. The protein contains characteristic AAA+ domains that facilitate ATP hydrolysis, coupled with a zinc-dependent proteolytic domain. In mitochondria, paraplegin works alongside AFG3L2, another AAA+ protease, to form the m-AAA protease complex. This complex maintains mitochondrial proteostasis by selectively removing oxidatively damaged proteins, misfolded polypeptides, and regulatory proteins involved in energy metabolism.
...
SPG7
Overview
SPG7 (Spastic Paraplegia 7) encodes paraplegin, a mitochondrial metalloproteinase that belongs to the AAA+ (ATPases associated with diverse cellular activities) family of proteins. The SPG7 gene is located on the X chromosome and represents one of the most common genetic causes of hereditary spastic paraplegia (HSP), a group of inherited neurological disorders characterized by progressive lower limb weakness and spasticity. Mutations in SPG7 account for approximately 5-10% of X-linked HSP cases and are also found in some autosomal recessive forms of the disease. The protein functions as part of the m-AAA protease complex within the inner mitochondrial membrane, making it essential for mitochondrial protein quality control and cellular energy metabolism.
Function/Biology
Paraplegin is an ATP-dependent protease that oligomerizes to form a hexameric ring structure capable of unfolding and degrading damaged or misfolded proteins within the mitochondrial matrix and inner membrane. The protein contains characteristic AAA+ domains that facilitate ATP hydrolysis, coupled with a zinc-dependent proteolytic domain. In mitochondria, paraplegin works alongside AFG3L2, another AAA+ protease, to form the m-AAA protease complex. This complex maintains mitochondrial proteostasis by selectively removing oxidatively damaged proteins, misfolded polypeptides, and regulatory proteins involved in energy metabolism.
The biological functions of SPG7/paraplegin extend beyond simple protein degradation. The protein plays crucial roles in regulating respiratory chain assembly, particularly the organization and stability of respiratory chain complexes I, III, IV, and V. SPG7 also participates in mitochondrial dynamics by regulating the processing of optic atrophy 1 (OPA1), a dynamin-like GTPase essential for mitochondrial fusion and cristae remodeling. Additionally, paraplegin influences calcium homeostasis and ATP production efficiency within mitochondria, making it indispensable for maintaining cellular energy status in neurons with high metabolic demands.
Role in Neurodegeneration
Mutations in SPG7 lead to progressive degeneration of long descending motor tracts in the spinal cord, resulting in the characteristic clinical phenotype of hereditary spastic paraplegia. The selective vulnerability of long corticospinal tract axons suggests that SPG7 dysfunction particularly impacts neurons with extensive axonal projections that depend critically on robust mitochondrial function. Loss of paraplegin activity impairs mitochondrial protein quality control, leading to accumulation of damaged proteins, respiratory chain dysfunction, and compromised ATP production. This progressive energy deficit ultimately triggers axonal degeneration and neuronal loss, particularly affecting motor neurons.
SPG7-associated neurodegeneration involves secondary pathological processes including oxidative stress from dysfunctional respiratory chains, calcium dysregulation, and activation of intrinsic apoptotic pathways. The impaired mitochondrial dynamics resulting from defective OPA1 processing may also contribute to neuronal vulnerability by promoting mitochondrial fragmentation and reducing ATP supply to distal axons.
Molecular Mechanisms
SPG7 mutations cause neurodegeneration through loss-of-function mechanisms. Missense mutations often disrupt the ATP-binding or proteolytic domains, abolishing catalytic activity. Nonsense mutations and frameshift mutations result in truncated proteins lacking functional domains. The molecular consequences of SPG7 dysfunction include:
Accumulation of respiratory chain subunits and oxidatively damaged proteins within mitochondria
Defective assembly and organization of oxidative phosphorylation complexes
Impaired mitochondrial fusion due to aberrant OPA1 processing
Reduced ATP production and increased reactive oxygen species
Mitochondrial calcium overload and compromised cellular signaling
Clinical/Research Significance
SPG7 mutations account for a substantial proportion of genetic HSP cases, making genetic testing of this gene clinically important for diagnosis. Research into SPG7 function has revealed fundamental principles of mitochondrial protein quality control and highlighted the critical importance of mitochondrial dynamics in long-axon neuron survival. Studies of SPG7-deficient animal models have provided insights into mechanisms of neurodegeneration and potential therapeutic targets, including interventions targeting mitochondrial proteostasis, respiratory chain function, and mitochondrial dynamics.
Related Entities
AFG3L2 - functionally related AAA+ protease that cooperates with paraplegin